Immune checkpoint inhibitor related myositis: an observational, retrospective, pharmacovigilance study
CONCLUSIONS: Clinicians should be aware of the potential for ICI-associated myositis, as it can be particularly life-threatening, especially in elderly patients or when it occurs concurrently with other AEs such as myocarditis or severe myasthenia gravis.PMID:38629402 | DOI:10.1080/14740338.2024.2343023 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 17, 2024 Category: Drugs & Pharmacology Authors: Hezhe Lu Hui Yang Zhexin Ding Zhuoling An Yong Zhao Source Type: research
Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors: a post-marketing study based on FAERS database using signal detection algorithms
CONCLUSION: Several significant disproportionality signals were observed with DPP-4 inhibitors. However, clinicians have to consider the comorbidities and concomitant drugs while prescribing these drugs.PMID:38626310 | DOI:10.1080/14740338.2024.2343015 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 16, 2024 Category: Drugs & Pharmacology Authors: Dipika Bansal Beema T Yoosuf Muhammed Favas Kt Pinaki Dutta Source Type: research
A real ‑world pharmacovigilance study of FDA adverse event reporting system events for daratumumab
CONCLUSION: Our study found potential new and unexpected AEs signals for daratumumab, suggesting prospective clinical studies are needed to confirm these results and illustrate their relationship.PMID:38600747 | DOI:10.1080/14740338.2024.2328321 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Xiaolin Yun Yingying Zhou Danna Wu Yuanbo Liu Qiongshi Wu Source Type: research
Long-term safety of lanthanum carbonate in the real word: a 19-year disproportionality analysis from the FDA Adverse Event Reporting System
CONCLUSIONS: This study affirms lanthanum carbonate's long-term safety for reducing elevated blood phosphorus levels. While gastrointestinal disorders were common, attention must focus on emerging AEs, particularly stress, especially in elderly patients.PMID:38602862 | DOI:10.1080/14740338.2024.2343014 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Mengjia Ying Jian Shi Yahao Ling Tao Shi Lele Liao Linhui Cao Source Type: research
Antibiotics-associated pseudomembranous colitis: a disproportionality analysis of the US food and drug administration adverse event reporting system (FAERS) database
CONCLUSIONS: This study was of great significance for healthcare professionals to realize the potential PMC risks of antibiotics.PMID:38603461 | DOI:10.1080/14740338.2024.2341813 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Jinhua Chen Weijiang Yu Wancun Zhang Cuicui Sun Wenzhou Zhang Source Type: research
A real ‑world pharmacovigilance study of FDA adverse event reporting system events for daratumumab
CONCLUSION: Our study found potential new and unexpected AEs signals for daratumumab, suggesting prospective clinical studies are needed to confirm these results and illustrate their relationship.PMID:38600747 | DOI:10.1080/14740338.2024.2328321 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Xiaolin Yun Yingying Zhou Danna Wu Yuanbo Liu Qiongshi Wu Source Type: research
Long-term safety of lanthanum carbonate in the real word: a 19-year disproportionality analysis from the FDA Adverse Event Reporting System
CONCLUSIONS: This study affirms lanthanum carbonate's long-term safety for reducing elevated blood phosphorus levels. While gastrointestinal disorders were common, attention must focus on emerging AEs, particularly stress, especially in elderly patients.PMID:38602862 | DOI:10.1080/14740338.2024.2343014 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Mengjia Ying Jian Shi Yahao Ling Tao Shi Lele Liao Linhui Cao Source Type: research
Antibiotics-associated pseudomembranous colitis: a disproportionality analysis of the US food and drug administration adverse event reporting system (FAERS) database
CONCLUSIONS: This study was of great significance for healthcare professionals to realize the potential PMC risks of antibiotics.PMID:38603461 | DOI:10.1080/14740338.2024.2341813 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Jinhua Chen Weijiang Yu Wancun Zhang Cuicui Sun Wenzhou Zhang Source Type: research
A real ‑world pharmacovigilance study of FDA adverse event reporting system events for daratumumab
CONCLUSION: Our study found potential new and unexpected AEs signals for daratumumab, suggesting prospective clinical studies are needed to confirm these results and illustrate their relationship.PMID:38600747 | DOI:10.1080/14740338.2024.2328321 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Xiaolin Yun Yingying Zhou Danna Wu Yuanbo Liu Qiongshi Wu Source Type: research
Long-term safety of lanthanum carbonate in the real word: a 19-year disproportionality analysis from the FDA Adverse Event Reporting System
CONCLUSIONS: This study affirms lanthanum carbonate's long-term safety for reducing elevated blood phosphorus levels. While gastrointestinal disorders were common, attention must focus on emerging AEs, particularly stress, especially in elderly patients.PMID:38602862 | DOI:10.1080/14740338.2024.2343014 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Mengjia Ying Jian Shi Yahao Ling Tao Shi Lele Liao Linhui Cao Source Type: research
Antibiotics-associated pseudomembranous colitis: a disproportionality analysis of the US food and drug administration adverse event reporting system (FAERS) database
CONCLUSIONS: This study was of great significance for healthcare professionals to realize the potential PMC risks of antibiotics.PMID:38603461 | DOI:10.1080/14740338.2024.2341813 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Jinhua Chen Weijiang Yu Wancun Zhang Cuicui Sun Wenzhou Zhang Source Type: research
A real ‑world pharmacovigilance study of FDA adverse event reporting system events for daratumumab
CONCLUSION: Our study found potential new and unexpected AEs signals for daratumumab, suggesting prospective clinical studies are needed to confirm these results and illustrate their relationship.PMID:38600747 | DOI:10.1080/14740338.2024.2328321 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Xiaolin Yun Yingying Zhou Danna Wu Yuanbo Liu Qiongshi Wu Source Type: research
Long-term safety of lanthanum carbonate in the real word: a 19-year disproportionality analysis from the FDA Adverse Event Reporting System
CONCLUSIONS: This study affirms lanthanum carbonate's long-term safety for reducing elevated blood phosphorus levels. While gastrointestinal disorders were common, attention must focus on emerging AEs, particularly stress, especially in elderly patients.PMID:38602862 | DOI:10.1080/14740338.2024.2343014 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Mengjia Ying Jian Shi Yahao Ling Tao Shi Lele Liao Linhui Cao Source Type: research
Antibiotics-associated pseudomembranous colitis: a disproportionality analysis of the US food and drug administration adverse event reporting system (FAERS) database
CONCLUSIONS: This study was of great significance for healthcare professionals to realize the potential PMC risks of antibiotics.PMID:38603461 | DOI:10.1080/14740338.2024.2341813 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - April 11, 2024 Category: Drugs & Pharmacology Authors: Jinhua Chen Weijiang Yu Wancun Zhang Cuicui Sun Wenzhou Zhang Source Type: research
